Conduit Pharmaceuticals (NASDAQ:CDT) has approved a 1-for-15 reverse stock split of the company’s common stock.
The reverse stock split will become effective on May 19, 2025, and the common stock is expected to begin trading on a reverse stock split-adjusted basis on The Nasdaq Global Market on May 20, 2025.